CS-5005-R

N/A

Report date: 2025/10/22 16:01:08

Base Information

Drug NameCS-5005-R

Drug Alias NameCS-5005-R

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Radiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionG-protein coupled receptor modulatorsSomatostatin receptor 2 modulators

TargetsG-protein coupled receptorSomatostatin receptor 2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesCstone Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesCstone Pharmaceuticals

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A